文献速递烧伤创面修复

磺胺嘧啶银敷料每日一次与每日两次更换在烧伤创面治疗中的疗效、安全性与耐受性评估

Evaluating the Efficacy, Safety, and Tolerance of Silver Sulfadiazine Dressings Once Daily Versus Twice Daily in the Treatment of Burn Wounds.
PubMed 文献 · J Burn Care Res · 2021-01-01

本研究比较烧伤创面磺胺嘧啶银敷料每日一次与每日两次更换的效果,主要观察创面感染、医院获得性并发症、疼痛评分和住院时间。结果显示两组创面感染率相同(均为5.33%),每日一次组平均疼痛水平略低但差异无统计学意义(5.27 vs 5.25),医院相关并发症率更低(10.67% vs 6.67%),住院时间更短(11.97 vs 10.31),且每例患者平均每日SSD用量更少(320.14 g vs 202.12 g)。结论认为每日一次更换对创面结局无负面影响,且与住院时间缩短、疼痛减轻和医院获得性并发症减少相关。

要点

  • 每日一次与每日两次SSD更换的创面感染率相同,均为5.33%。
  • 每日一次组住院时间更短(10.31 vs 11.97),SSD日均用量更少(202.12 g vs 320.14 g)。
  • 每日一次组医院相关并发症率更低(6.67% vs 10.67%),疼痛评分差异无统计学意义。

核心结论

  • 每日一次SSD敷料更换对烧伤创面结局无负面影响,且与住院时间缩短、疼痛减轻和医院获得性并发症减少相关。
  • 因创面结局差异可忽略且无统计学意义,将标准护理改为每日一次可能有益。

研究设计与样本

  • 非劣效性分析,计划每组75例,把握度0.80。
  • 2019年1月1日前本院维持每日两次换药标准,此后入院患者改为每日一次换药。
  • 比较改变前75例与改变后75例患者的结局。

主要发现

  • 创面感染率两组相同(改变前5.33%,改变后5.33%)。
  • 平均每日疼痛水平改变前略高但差异可忽略且无统计学意义(改变前5.27,改变后5.25)。
  • 医院相关并发症率改变前更高(改变前10.67%,改变后6.67%)。
  • 住院时间改变前更长(改变前11.97,改变后10.31)。
  • 每例患者住院期间平均每日SSD用量改变前更高(改变前320.14 g,改变后202.12 g)。

临床怎么用

  • 可考虑将烧伤创面SSD敷料更换标准由每日两次改为每日一次。
  • 每日一次换药可能缩短住院时间并减少SSD用量。
  • 每日一次换药未增加创面感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Topical silver sulfadiazine (SSD) is an effective antimicrobial therapy used to prevent burn wound infection and promote healing, but the frequency of application has not been previously examined. This study compares once versus twice daily dressing changes with SSD, focusing on development of wound infections, incidence of hospital acquired complications, patient pain scores, and length of stay. The objective of this study was to evaluate whether a once-daily or twice-daily application of SSD impacts burn wound healing outcomes. Our institution maintained a twice-daily dressing change standard of care until January 1, 2019. Patients admitted after that date had their dressing changed once daily. We performed a noninferiority analysis which indicated that a sample size of 75 per group would be sufficient to detect a significant difference with a power of 0.80. Our goal is to review outcomes for 75 patients before the change-of-practice and 75 patients after. Our main outcomes recorded are wound infection, average pain scores, average daily narcotic requirements, and length-of-stay. Results from 75 pre-change-of-practice and 75 post-change-of-practice patients showed slightly better outcomes in the post-change-of-practice group. The wound-infection rates were the same for both groups (pre = 5.33%, post = 5.33%), average daily pain levels for the pre-change group were slightly higher but the difference was negligible and not statistically significant (pre = 5.27, post = 5.25), hospital-related complication rates (unrelated to wound care) were higher pre-change (pre = 10.67%, post = 6.67%), and length-of-stay, was longer in the pre-change group (pre = 11.97, post = 10.31). The amount average amount of SSD (g/day) used per patient per hospital stay was higher as well (pre = 320.14, post = 202.12). Further statistical analysis of the results, particularly in the distribution of burn type, age, and burn depth showed no discrepancy and a generalized decreased length-of-stay with once-daily SSD dressing change. Our results show that once-daily dressing changes of SSD in burn wounds have no negative impact on wound outcomes. However, it is associated with a decreased length-of-stay, decreased pain levels, and less hospital-acquired complications. A decreased length-of-stay means reduced medical expenses for the patient and the hospital. In addition, less hospital-acquired complications result in better patient recovery. Since the difference in wound outcomes is negligible and statistically insignificant, changing the standard-of-care to once daily could prove beneficial.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Lagziel T, Asif M, Born L, et al. Evaluating the Efficacy, Safety, and Tolerance of Silver Sulfadiazine Dressings Once Daily Versus Twice Daily in the Treatment of Burn Wounds. J Burn Care Res. 2021. PMID: 34363678. doi:10.1093/jbcr/irab141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。